IP Library Granted Patent US 12,458,532
Granted Patent B2
US 12,458,532 · App. 18/311,673 · Granted Nov 4, 2025

Multi-dose ocular fluid delivery system

Inventors: Reynaldo Quintana (Menlo Park, CA); Yehuda Ivri (Newport Coast, CA)
Assignee: Bausch + Lomb Ireland Limited
A61F9/0026
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,458,532
App. No.
18/311,673
Granted
Nov 4, 2025
Kind
B2
Abstract

Multi-dose ocular fluid delivery devices are provided. Aspects of the fluid delivery devices include a fluid package and an actuator. The fluid package includes a reservoir of an ophthalmic formulation, an aperture and a valve member for sealing the aperture when fluid is not being ejected therethrough. The actuator operates the valve member so as to at least reduce, if not prevent, ingress of outside materials or contaminants into the reservoir. Also provided are methods of using the devices in fluid delivery applications, as well as a kit that includes components of the devices.

Claims (30)

1 . A method for dispensing a liquid to an eye of a patient, the method comprising:

aligning, with the eye to receive the liquid, a device having a reservoir within which the liquid is accommodated, one or more apertures through which the liquid from the reservoir is dispensed, a valve member having a tip in a fluid-tight seal with the one or more apertures, and an actuator to deliver mechanical vibration directly to the valve member so that the tip of the valve member is disengaged from the one or more apertures to permit the liquid to be dispensed from the reservoir;

activating the actuator to deliver the mechanical vibrations to at least the valve member to disengage the valve member from the one or more apertures and to dispense the liquid through the one or more apertures; and

delivering a volume of good to the eye of the patient;

where the device includes a diaphragm which is affixed to the valve member and upon which the actuator delivers mechanical vibration to generate pressure in the liquid to dispense the liquid through the one or more apertures.

2 . The method of claim 1 , wherein the device includes a vent to equalize pressure in the reservoir as the liquid is dispensed.

3 . The method of claim 2 , wherein the vent is designed to prevent ingress of microbial and other contaminants into the reservoir.

4 . The method of claim 2 , wherein the vent is designed to prevent passage of microbes of 0.15 μm or less.

5 . The method of claim 1 , wherein the delivered volume of the liquid is 1 to 15 μl.

6 . The method of claim 5 , wherein the delivered volume of the liquid is 5 to 10 μl.

7 . The method of claim 1 , wherein the liquid is an ophthalmic liquid.

8 . The method of claim 1 , wherein the liquid is designed to treat glaucoma.

9 . The method of claim 1 , wherein the liquid includes an intraocular pressure modulatory agent to reduce pressure in the eye.

10 . The method of claim 1 , wherein the delivering step is completed within 150 ms.

11 . The method of claim 1 , wherein the delivering step is completed below a blink response time of the patient.

12 . The method of claim 1 , the method further comprising:

removing and replacing at least the reservoir when the liquid contained therein has been dispensed.

13 . The method of claim 1 , wherein the method is completed by the patient.

14 . The method of claim 1 , wherein the aligning step includes aligning the device with a region of the eye that is offset from a center of the eye.

15 . The method of claim 14 , wherein the offset is 1 to 20 mm from the center of the eye.

16 . The method of claim 1 , the method further comprising:

treating a disease or a medical condition by delivering the liquid to the eye.

17 . The method of claim 16 , wherein the treating step includes one or more of the following:

preventing the disease or condition from occurring,

ameliorating the disease or condition,

suppressing the disease or condition, or

alleviating a symptom of the disease or condition.

18 . The method of claim 1 , wherein the volume is accommodated by a tear film of the eye.

19 . The method of claim 1 , the method further comprising:

assembling the device in a manner provided by instructions.

Assignments (7)
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (066694/0131) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072460/0655 →
PATENT SECURITY AGREEMENT Recorded Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 29, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 066707/0684 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 27, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066694/0131 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2023
From: NOVARTIS AG
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 065531/0583 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2023
From: QUINTANA, REYNALDO; IVRI, YEHUDA
To: KEDALION THERAPEUTICS, INC.
Reel/Frame 064492/0108 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2023
From: KEDALION THERAPEUTICS, INC.
To: NOVARTIS AG
Reel/Frame 064492/0281 →